Literature DB >> 23768490

Networking at the level of host immunity: immune cell interactions during persistent viral infections.

Cherie T Ng1, Laura M Snell, David G Brooks, Michael B A Oldstone.   

Abstract

Persistent viral infections are the result of a series of connected events that culminate in diminished immunity and the inability to eliminate infection. By building our understanding of how distinct components of the immune system function both individually and collectively in productive versus abortive responses, new potential therapeutic targets can be developed to overcome immune dysfunction and thus fight persistent infections. Using lymphocytic choriomeningitis virus (LCMV) as a model of a persistent virus infection and drawing parallels to persistent human viral infections such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV), we describe the cellular relationships and interactions that determine the outcome of initial infection and highlight immune targets for therapeutic intervention to prevent or treat persistent infections. Ultimately, these findings will further our understanding of the immunologic basis of persistent viral infection and likely lead to strategies to treat human viral infections.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23768490      PMCID: PMC3713852          DOI: 10.1016/j.chom.2013.05.014

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  148 in total

1.  IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.

Authors:  Galit Alter; Daniel Kavanagh; Suzannah Rihn; Rutger Luteijn; David Brooks; Michael Oldstone; Jan van Lunzen; Marcus Altfeld
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

2.  Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.

Authors:  Florian Klein; Ron Diskin; Johannes F Scheid; Christian Gaebler; Hugo Mouquet; Ivelin S Georgiev; Marie Pancera; Tongqing Zhou; Reha-Baris Incesu; Brooks Zhongzheng Fu; Priyanthi N P Gnanapragasam; Thiago Y Oliveira; Michael S Seaman; Peter D Kwong; Pamela J Bjorkman; Michel C Nussenzweig
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

3.  Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner.

Authors:  Daniel L Popkin; John R Teijaro; Brian M Sullivan; Shuzo Urata; Sophie Rutschmann; Juan Carlos de la Torre; Stefan Kunz; Bruce Beutler; Michael Oldstone
Journal:  Cell Host Microbe       Date:  2011-03-17       Impact factor: 21.023

4.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Authors:  Scott N Mueller; Mehrdad Matloubian; Daniel M Clemens; Arlene H Sharpe; Gordon J Freeman; Shivaprakash Gangappa; Christian P Larsen; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.

Authors:  Simona Urbani; Barbara Amadei; Daniela Tola; Giuseppe Pedrazzi; Luca Sacchelli; Maria Cristina Cavallo; Alessandra Orlandini; Gabriele Missale; Carlo Ferrari
Journal:  J Hepatol       Date:  2008-01-28       Impact factor: 25.083

7.  CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus.

Authors:  Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  J Immunol       Date:  2012-11-07       Impact factor: 5.422

8.  Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.

Authors:  Michael A Paley; Daniela C Kroy; Pamela M Odorizzi; Jonathan B Johnnidis; Douglas V Dolfi; Burton E Barnett; Elizabeth K Bikoff; Elizabeth J Robertson; Georg M Lauer; Steven L Reiner; E John Wherry
Journal:  Science       Date:  2012-11-30       Impact factor: 47.728

9.  Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.

Authors:  Daniel Mendoza; Stephen A Migueles; Julia E Rood; Bennett Peterson; Sarah Johnson; Nicole Doria-Rose; Douglas Schneider; Eva Rakasz; Matthew T Trivett; Charles M Trubey; Vicky Coalter; Claire W Hallahan; David Watkins; Genoveffa Franchini; Jeffrey D Lifson; Mark Connors
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

10.  Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification.

Authors:  Henning Lauterbach; Phi Truong; Dorian B McGavern
Journal:  Virol J       Date:  2007-06-06       Impact factor: 4.099

View more
  41 in total

1.  Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients.

Authors:  M Guzmán-Fulgencio; J Berenguer; D Pineda-Tenor; M A Jiménez-Sousa; M García-Álvarez; T Aldámiz-Echevarria; A Carrero; C Diez; F Tejerina; S Vázquez; V Briz; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-19       Impact factor: 3.267

2.  Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.

Authors:  Ivan Osokine; Laura M Snell; Cameron R Cunningham; Douglas H Yamada; Elizabeth B Wilson; Heidi J Elsaesser; Juan Carlos de la Torre; David Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

Review 3.  CD8+ T cell exhaustion.

Authors:  Makoto Kurachi
Journal:  Semin Immunopathol       Date:  2019-04-15       Impact factor: 9.623

Review 4.  Molecular and cellular insights into T cell exhaustion.

Authors:  E John Wherry; Makoto Kurachi
Journal:  Nat Rev Immunol       Date:  2015-08       Impact factor: 53.106

5.  Association between chronic hepatitis C and hepatitis C/HIV co-infection and the development of colorectal adenomas.

Authors:  Jorge Hurtado-Cordovi; Ashley H Davis-Yadley; Seth Lipka; Magdalene Vardaros; Huafeng Shen
Journal:  J Gastrointest Oncol       Date:  2016-08

6.  Targeting type I interferon-mediated activation restores immune function in chronic HIV infection.

Authors:  Anjie Zhen; Valerie Rezek; Cindy Youn; Brianna Lam; Nelson Chang; Jonathan Rick; Mayra Carrillo; Heather Martin; Saro Kasparian; Philip Syed; Nicholas Rice; David G Brooks; Scott G Kitchen
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

7.  Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection.

Authors:  Laura M Snell; Ivan Osokine; Douglas H Yamada; Justin Rafael De la Fuente; Heidi J Elsaesser; David G Brooks
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

Review 8.  Innate immune cell networking in hepatitis C virus infection.

Authors:  Banishree Saha; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

9.  A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose.

Authors:  Rekha Dhanwani; Yanqin Zhou; Qinfeng Huang; Vikram Verma; Mythili Dileepan; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

10.  Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence.

Authors:  Caleb J Studstill; Curtis J Pritzl; Young-Jin Seo; Dae Young Kim; Chuan Xia; Jennifer J Wolf; Ravi Nistala; Madhuvanthi Vijayan; Yong-Bin Cho; Kyung Won Kang; Sang-Myeong Lee; Bumsuk Hahm
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.